General Information of the Ferroptosis Regulator (ID: REG30056)
Regulator Name RUNX1-IT1 (IncRNA)
Synonyms
RUNX1-IT1
    Click to Show/Hide
Gene Name C21orf96; RUNX1 intronic transcript 1
Gene ID 80215
Regulator Type lncRNA
Ensembl ID .
HGNC ID
HGNC:16623
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
C21orf96; RUNX1 intronic transcript 1 can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Phospholipid hydroperoxide glutathione peroxidase (GPX4) [Suppressor]
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis Target of This Regulator [1]
Target for Ferroptosis Suppressor
Responsed Disease Breast cancer ICD-11: 2C60
Pathway Response Ferroptosis hsa04216
Cell Process Cell ferroptosis
In Vitro Model
T-47D cells Invasive breast carcinoma Homo sapiens CVCL_0553
MDA-MB-231 cells Breast adenocarcinoma Homo sapiens CVCL_0062
In Vivo Model
MDA-MB-231 cells with stable RUNX1-IT1 knockdown were injected into NOD/SCID mice, which were randomly divided into three groups, five in each group. The protocol of establishment of breast cancer orthotopic transplantation model was described in our previous study.

    Click to Show/Hide
Response regulation RUNX1-IT1 promotes breast cancer carcinogenesis through blocking ferroptosis via elevating GPX4, targeting of the previously unappreciated regulatory axis of RUNX1-IT1/IGF2BP1/GPX4 may be a promising treatment for patient with breast cancer.
Breast cancer [ICD-11: 2C60]
In total 1 item(s) under this disease
Experiment 1 Reporting the Ferroptosis-centered Disease Response [1]
Target Regulator RUNX1-IT1 (IncRNA) lncRNA
Pathway Response Ferroptosis hsa04216
Cell Process Cell ferroptosis
In Vitro Model
T-47D cells Invasive breast carcinoma Homo sapiens CVCL_0553
MDA-MB-231 cells Breast adenocarcinoma Homo sapiens CVCL_0062
In Vivo Model
MDA-MB-231 cells with stable RUNX1-IT1 knockdown were injected into NOD/SCID mice, which were randomly divided into three groups, five in each group. The protocol of establishment of breast cancer orthotopic transplantation model was described in our previous study.

    Click to Show/Hide
Response regulation RUNX1-IT1 promotes breast cancer carcinogenesis through blocking ferroptosis via elevating GPX4, targeting of the previously unappreciated regulatory axis of RUNX1-IT1/IGF2BP1/GPX4 may be a promising treatment for patient with breast cancer.
References
Ref 1 RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis. Discov Oncol. 2023 Apr 10;14(1):42. doi: 10.1007/s12672-023-00652-z.